Vivek Agarwal, MD
Allergy & Immunology · Silverdale, WANPI 1467682799
Payments from drug & device makers
Across 534 payments — averaging $21.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Sanofi$1K
- GSK$1K
- Octapharma USA, Inc.$531
- Biocryst US Sales Co., LLC$405
- plus $4K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 122 | $2,810 |
| Takeda Pharmaceuticals U.S.A., Inc. | 64 | $1,163 |
| Sanofi | 48 | $1,037 |
| GSK | 62 | $1,032 |
| Octapharma USA, Inc. | 8 | $531 |
| Biocryst US Sales Co., LLC | 19 | $405 |
| Grifols USA, LLC | 21 | $397 |
| Genentech USA, Inc. | 20 | $389 |
| CSL Behring | 18 | $387 |
| Pfizer | 15 | $381 |
| Boehringer Ingelheim | 26 | $335 |
| Kaleo, Inc. | 15 | $306 |
| Novartis | 14 | $293 |
| Amgen(2 entities) | 14 | $275 |
| Regeneron Healthcare Solutions, Inc. | 13 | $254 |
| Teva Pharmaceuticals USA, Inc. | 10 | $184 |
| Medtronic | 1 | $181 |
| ADMA Biomanufacturing LLC | 6 | $154 |
| LEO Pharma Inc. | 7 | $126 |
| Pharming Healthcare, Inc. | 6 | $119 |
| Blueprint Medicines Corporation | 3 | $108 |
| Alk-abello, Inc | 5 | $99 |
| Mylan Specialty L.p. | 3 | $66 |
| Ionis Pharmaceuticals, Inc. | 2 | $41 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
| Bayer | 2 | $39 |
| Tersera Therapeutics LLC | 1 | $30 |
| Johnson & Johnson | 2 | $29 |
| Sunovion Pharmaceuticals Inc. | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| AbbVie | 1 | $21 |
| Incyte Corporation | 1 | $20 |
| Biocryst Pharmaceuticals, Inc. | 1 | $18 |
How this compares
$11,317 in reported general payments places this provider in the 75th percentile of 81 allergy & immunology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Silverdale
- Michelle MontalbanoSilverdale$21K
- Mary MaierSilverdale$1K
- David ElkayamBellingham$2.1M
- Daniel PetroniSeattle$2M
- Richard GowerSpokane$1.1M
- Sanjeev JainLongview$392K
- William HendersonSeattle$296K
- Taiil SongLakewood$192K
- Mary FarringtonSeattle$176K
- Frank VirantSeattle$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.